Dual antiplatelet therapy duration: what are the drivers?

Abstract

PURPOSE OF REVIEW To address the evidence, or lack thereof, of dual antiplatelet therapy (DAPT) duration in the percutaneous coronary intervention (PCI) setting. RECENT FINDINGS The most recent guidelines on DAPT in the PCI setting are rather discordant about the duration of therapy and refer to results of studies which are often controversial. We… (More)
DOI: 10.1097/01.hco.0000409959.11246.ba

6 Figures and Tables

Topics

  • Presentations referencing similar topics